● Live · 13 days left

RFP-Engagement of NABL Accredited Diagnostic Laboratory

Jhpiego Corporation, India
Deadline Aug 27, 2026
Type Procurement of Services
Location India
Submission Email

Description

Jhpiego Corporation, India

REQUESTFORPROPOSAL (RFP)

SUBJECT: RFP for engagement of NABL Accredited Diagnostic Laboratory

ISSUE DATE: August 14, 2026

SUBMISSION DEADLINE: August 27, 2026

SUBMISSION ADDRESS:  jhpin.procurement@jhpiego.org (For submission of proposals)

Email:Ankur.Bhardwaj@jhpiego.org (For queries only) -submit queries by August 18, 2026 (Tuesday)

Office Telephone: Tel: +91 11 49575100

Pre-bid meeting 19 August 2026 2.00 PM- 2.30 PM

Microsoft Teams meeting

Join: https://teams.microsoft.com/meet/2713062165598?p=84cRnjJfmgItL7S3Ru

Meeting ID: 271 306 216 559 8

Passcode: ca6wR9vS

BID OPENING: -August 28, 2026

AWARD /START DATE (selection of partner)-September 15, 2026 (tentative)

About Jhpiego:

Jhpiego is a nonprofit global health leader and Johns Hopkins University affiliate that is saving lives, improving health, and transforming futures. We partner with governments, health experts and local communities to build the skills and systems that guarantee a healthier future for women and families. Jhpiego translates the best science and practice into moments of care that can mean the difference between life and death for women and families. The moment a woman gives birth; the moment a midwife helps a newborn to breath. Through our partnerships, we are revolutionizing health care for the world’s most disadvantaged and vulnerable people.

 

In India, Jhpiego works across various states in close collaboration with national and state governments, providing technical assistance in the areas of family planning, maternal and child health, strengthening human resources for health, and non-communicable diseases. These programs are funded by Takeda Pharmaceutical Company Limited, Unitaid, UNICEF, World Health Organization, University of Manitoba, Bill & Melinda Gates Foundation, Children’s Investment Fund Foundation (CIFF), MSD for Mothers and others. Multiple programs implemented by Jhpiego with different state governments are having specific learning agenda and objectives. Each program involves wide range of data collection in various implementation geographies across India.

About the project- Jhpiego, in collaboration with the National TB Elimination Program (NTEP), Government of Odisha, is implementing an intervention to identify tuberculosis infection (TB Infection/TBI) among individuals at increased risk of developing active tuberculosis. The project aims to facilitate early identification of TB infection among selected high-risk populations through Interferon Gamma Release Assay (IGRA) testing and support timely referral to NTEP for further clinical evaluation and consideration of TB Preventive Treatment (TPT), as per prevailing national guidelines.

The intervention will be implemented in selected public health facilities in Boudh and Dhenkanal districts of Odisha and will cover approximately 2,000 eligible beneficiaries through a combination of facility-based and home-based blood sample collection services. The target population includes individuals with Diabetes Mellitus (DM), Chronic Kidney Disease (CKD), including patients undergoing dialysis, cancer patients attending oncology/day-care services, and any additional high-risk groups identified by the project during implementation.

 

Jhpiego intends to engage an experienced NABL-accredited diagnostic laboratory to provide end-to-end laboratory services, including sample collection, transportation, IGRA testing, quality assurance, reporting, and data sharing in accordance with applicable national guidelines and manufacturer specifications.

 

2. Objective

The objective of this engagement is to provide reliable, timely, and quality-assured IGRA testing services for approximately 2,000 beneficiaries in Boudh and Dhenkanal districts by ensuring efficient sample collection, transportation, laboratory testing, reporting, and coordination with the project team throughout the implementation period ending 31 March 2027.

  • The laboratory shall ensure that all services are delivered in accordance with accepted laboratory quality standards while maintaining specimen integrity, beneficiary confidentiality, and agreed turnaround timelines.
  • Geographies: Boudh and Dhenkanal, Odisha

Preferred vendor: None

This RFP includes following:

Section 1 - Instructions to bidders

Section 2 - Technical Proposal - Standard Template

Section 3 - Financial Proposal - Standard Template

Section 4 - Scope of Work

Section 5 – Vendor Information Form– Standard Template

Section 6 - Standard Template of Technical Service Contract

 

 

For detailed information, please check the complete version of the RFP attached below.

Job Email ID: jhpin.procurement(at)jhpiego.org


Download Attachment: RFP for engagement of NABL Accredited Diagnostic Laboratory.docx

Documents

RFP for engagement of NABL Accredited Diagnostic Laboratory Tender Document
Download

Description

Jhpiego Corporation, India

REQUESTFORPROPOSAL (RFP)

SUBJECT: RFP for engagement of NABL Accredited Diagnostic Laboratory

ISSUE DATE: August 14, 2026

SUBMISSION DEADLINE: August 27, 2026

SUBMISSION ADDRESS:  jhpin.procurement@jhpiego.org (For submission of proposals)

Email:Ankur.Bhardwaj@jhpiego.org (For queries only) -submit queries by August 18, 2026 (Tuesday)

Office Telephone: Tel: +91 11 49575100

Pre-bid meeting 19 August 2026 2.00 PM- 2.30 PM

Microsoft Teams meeting

Join: https://teams.microsoft.com/meet/2713062165598?p=84cRnjJfmgItL7S3Ru

Meeting ID: 271 306 216 559 8

Passcode: ca6wR9vS

BID OPENING: -August 28, 2026

AWARD /START DATE (selection of partner)-September 15, 2026 (tentative)

About Jhpiego:

Jhpiego is a nonprofit global health leader and Johns Hopkins University affiliate that is saving lives, improving health, and transforming futures. We partner with governments, health experts and local communities to build the skills and systems that guarantee a healthier future for women and families. Jhpiego translates the best science and practice into moments of care that can mean the difference between life and death for women and families. The moment a woman gives birth; the moment a midwife helps a newborn to breath. Through our partnerships, we are revolutionizing health care for the world’s most disadvantaged and vulnerable people.

 

In India, Jhpiego works across various states in close collaboration with national and state governments, providing technical assistance in the areas of family planning, maternal and child health, strengthening human resources for health, and non-communicable diseases. These programs are funded by Takeda Pharmaceutical Company Limited, Unitaid, UNICEF, World Health Organization, University of Manitoba, Bill & Melinda Gates Foundation, Children’s Investment Fund Foundation (CIFF), MSD for Mothers and others. Multiple programs implemented by Jhpiego with different state governments are having specific learning agenda and objectives. Each program involves wide range of data collection in various implementation geographies across India.

About the project- Jhpiego, in collaboration with the National TB Elimination Program (NTEP), Government of Odisha, is implementing an intervention to identify tuberculosis infection (TB Infection/TBI) among individuals at increased risk of developing active tuberculosis. The project aims to facilitate early identification of TB infection among selected high-risk populations through Interferon Gamma Release Assay (IGRA) testing and support timely referral to NTEP for further clinical evaluation and consideration of TB Preventive Treatment (TPT), as per prevailing national guidelines.

The intervention will be implemented in selected public health facilities in Boudh and Dhenkanal districts of Odisha and will cover approximately 2,000 eligible beneficiaries through a combination of facility-based and home-based blood sample collection services. The target population includes individuals with Diabetes Mellitus (DM), Chronic Kidney Disease (CKD), including patients undergoing dialysis, cancer patients attending oncology/day-care services, and any additional high-risk groups identified by the project during implementation.

 

Jhpiego intends to engage an experienced NABL-accredited diagnostic laboratory to provide end-to-end laboratory services, including sample collection, transportation, IGRA testing, quality assurance, reporting, and data sharing in accordance with applicable national guidelines and manufacturer specifications.

 

2. Objective

The objective of this engagement is to provide reliable, timely, and quality-assured IGRA testing services for approximately 2,000 beneficiaries in Boudh and Dhenkanal districts by ensuring efficient sample collection, transportation, laboratory testing, reporting, and coordination with the project team throughout the implementation period ending 31 March 2027.

  • The laboratory shall ensure that all services are delivered in accordance with accepted laboratory quality standards while maintaining specimen integrity, beneficiary confidentiality, and agreed turnaround timelines.
  • Geographies: Boudh and Dhenkanal, Odisha

Preferred vendor: None

This RFP includes following:

Section 1 - Instructions to bidders

Section 2 - Technical Proposal - Standard Template

Section 3 - Financial Proposal - Standard Template

Section 4 - Scope of Work

Section 5 – Vendor Information Form– Standard Template

Section 6 - Standard Template of Technical Service Contract

 

 

For detailed information, please check the complete version of the RFP attached below.

Job Email ID: jhpin.procurement(at)jhpiego.org


Download Attachment: RFP for engagement of NABL Accredited Diagnostic Laboratory.docx

Tender Documents

RFP for engagement of NABL Accredited Diagnostic Laboratory Tender Document
Download

Submission Details

Method Email

Contact Person

Name Ankur Bhardwaj
SAMS-STC Follow on LinkedIn @sams_stc Follow on Instagram SAMS-STC Like us on Facebook